STOCKSCOPE

Synertec Corporation (ASX: SOP) Builds Momentum as $74.3 Million Contract Backlog Sets Stage for Major Growth

Alison Elzayed

Alison Elzayed

Business & Finance Writer | StockScope

Published:5d ago
Synertec Corporation (ASX: SOP) Builds Momentum as $74.3 Million Contract Backlog Sets Stage for Major Growth

Synertec Corporation (ASX: SOP) is entering a promising growth phase, with a $74.3 million contracted order book, upgraded FY2027 revenue guidance and expanding demand for its Powerhouse energy technology strengthening its commercial outlook.

A landmark $45.5 million nuclear engineering contract and improving financial performance suggest the company is moving towards a more sustainable earnings profile.

The key opportunity now lies in converting this substantial contracted workload into higher profitability and stronger cash generation.

Key Numbers

  • $74.3 million: Contracted work-in-hand at 30 September 2026, up 395% year-on-year.
  • $37.5 million to $40 million: FY2027 revenue guidance, representing expected growth of 77% to 89%.
  • $45.5 million: Engineering contract secured with the Australian Nuclear Science and Technology Organisation (ANSTO).
  • $5.9 million: September-quarter revenue, representing 18% year-on-year growth.
  • $12.9 million: Available funding at 30 September 2026, including $4.2 million in cash and $8.7 million in undrawn facilities.

Landmark Nuclear Contract Strengthens Revenue Visibility

The most significant development behind Synertec's improving outlook is its September 2026 agreement with ANSTO.

The $45.5 million contract supports the Nuclear Medicine Manufacturing Program at Lucas Heights, providing engineering services for nationally significant infrastructure.

Approximately $36 million is expected to be delivered during the initial 26-month design phase, establishing a substantial foundation of contracted revenue.

Management expects the agreement to generate a contribution margin exceeding 25%, highlighting its potential earnings significance. Importantly, this represents project-level contribution rather than net profitability.

The agreement also strengthens Synertec's positioning in specialised engineering markets where technical expertise, regulatory requirements and project complexity create meaningful barriers to entry.

Following the award, Synertec upgraded FY2027 revenue guidance from its previous range of $29.5 million to $31.7 million.

By 30 October, management confirmed that its revised full-year guidance was entirely supported by contracted work.

This provides greater confidence in the company's near-term revenue outlook, with execution and project margins becoming the principal determinants of financial performance.

Powerhouse Expansion Creates a Second Growth Opportunity

Beyond engineering, Synertec's proprietary Powerhouse technology is gaining commercial traction across Australia's industrial energy sector.

The renewable energy and battery-based platform provides reliable power for remote operations while reducing dependence on conventional diesel generation.

In September, Santos awarded Synertec an approximately $6 million contract for a 12MW/12MWh Powerhouse system supporting its Moomba operations.

Scheduled for delivery during the first half of FY2028, the project demonstrates the technology's capacity to serve larger industrial energy requirements.

At the September quarter-end, Synertec had 15 Powerhouse units contracted, comprising four operational systems and 11 undergoing design or construction.

Quarterly Powerhouse revenue increased 35% to $0.8 million, while its opportunity pipeline reached approximately $500 million.

Although pipeline opportunities remain subject to commercial conversion, the expanding scale of customer engagement suggests meaningful potential for future deployments.

Depending on contract structures, additional installations could support both equipment revenue and longer-term recurring income.

Improving Financial Performance Supports Growth Ambitions

Synertec's FY2026 financial results provide encouraging evidence that its commercial expansion is beginning to translate into operational improvement.

Group EBITDA improved from a $5.8 million loss in FY2025 to a $1.9 million loss in FY2026.

Annual operating cash flow strengthened by $4.6 million to a positive $0.5 million, demonstrating improving financial discipline.

The company also achieved monthly EBITDA breakeven in September 2026, an important milestone towards sustained profitability.

Nevertheless, September-quarter operating cash outflow reached $1.9 million, including approximately $1.1 million associated with timing and mobilisation requirements.

Synertec invested approximately $1.3 million during the quarter, primarily supporting Powerhouse development and deployment.

Its $12.9 million available funding position provides flexibility, although converting contracts into cash remains essential to limiting future financing requirements.

With profitability still developing, conventional earnings multiples offer limited valuation insight. Contract margins, cash conversion and recurring revenue growth provide more meaningful measures of business value.

Insight: Contracted Revenue Could Accelerate Synertec's Earnings Transformation

What stands out to us is how Synertec's substantial order book is beginning to align with measurable financial improvement. The $74.3 million contracted workload provides revenue visibility, while the ANSTO agreement's expected contribution margin above 25% creates an encouraging foundation for earnings growth. Combined with expanding Powerhouse deployments, this could support a more diversified and profitable business. We see particular potential if management converts these opportunities into sustained positive EBITDA, making quarterly operating cash flow the next critical measure of progress.

The Verdict: A Stronger Foundation for Sustainable Growth

Synertec's outlook appears increasingly constructive, supported by secured engineering revenue, improving operational performance and expanding commercial opportunities for Powerhouse.

The anticipated December 2026 investment decision for Amplitude Energy's potential Orbost Powerhouse project provides another development worth monitoring, although any commercial commitment remains conditional.

We see the most compelling opportunity in Synertec's ability to combine specialist engineering expertise with scalable industrial energy technology.

Execution risks, project timing and working-capital requirements remain important considerations.

However, with FY2027 revenue guidance fully contracted and profitability improving, Synertec appears better positioned to establish a sustainable earnings base as its next phase of growth unfolds.

Alison Elzayed

Alison Elzayed

(Business & Finance Writer | StockScope)

Alison Elzayed is an experienced business and financial writer with more than 10 years of experience in the publishing industry, having previously worked as an author with Bloomsbury Publishing, specialising in business and finance. Throughout her career, Alison has developed a strong understanding of financial markets, corporate developments, economic trends and investment-related topics. Her background in financial publishing has equipped her with the ability to research complex subjects and communicate them in a clear, accurate and engaging manner.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX slides to five-month low as AI sell-off rattles global markets
Market Briefings
Market Briefings

ASX slides to five-month low as AI sell-off rattles global markets

Australian equities: what moved the ASX 200? Australian shares extended their losing streak on Friday, with the S&P/ASX 200 falling 137.8 points, or 1.58%, to close at 8,592.6. This marked...

Mark ElzayedMark Elzayed•
NEXTDC (ASX: NXT) Raises FY27 Earnings Outlook as $140 Million Melbourne Opportunity Remains in Play
Technology
Technology

NEXTDC (ASX: NXT) Raises FY27 Earnings Outlook as $140 Million Melbourne Opportunity Remains in Play

NEXTDC Limited ASX: NXT has delivered an encouraging upgrade to its FY27 earnings guidance, highlighting the strength of its broader data centre business despite electricity supply delays at...

Danny AadDanny Aad•
Trek Metals (ASX: TKM) Hits 40.3% Manganese at Kuro as High-Grade Discovery Opens Up Bigger Potential
Mining
Mining

Trek Metals (ASX: TKM) Hits 40.3% Manganese at Kuro as High-Grade Discovery Opens Up Bigger Potential

A standout 25-metre intersection grading 31.4% manganese has delivered another encouraging result for Trek Metals Limited ASX: TKM, strengthening the exploration potential of its Kuro discov...

Alison ElzayedAlison Elzayed•
EBR Systems (ASX: EBR) Moves Closer to US-Wide Medicare Coverage as Major Growth Opportunity Emerges
Biotech & Health
Biotech & Health

EBR Systems (ASX: EBR) Moves Closer to US-Wide Medicare Coverage as Major Growth Opportunity Emerges

EBR Systems ASX: EBR has taken another significant step towards expanding the commercial reach of its wireless heart pacing technology, with US Medicare authorities proposing national covera...

Danny AadDanny Aad•
Orion Minerals (ASX: ORN) Unlocks US$6.7 Million From Glencore as Major Copper Production Milestone Approaches
Mining
Mining

Orion Minerals (ASX: ORN) Unlocks US$6.7 Million From Glencore as Major Copper Production Milestone Approaches

Orion Minerals ASX: ORN has reached a significant turning point in its copper and zinc development strategy, receiving its first US$6.7 million payment from global mining group Glencore. The...

Alison ElzayedAlison Elzayed•
EMVision Medical Devices (ASX: EMV) Unlocks a 1,700-Hospital Opportunity as Fresh Funding Accelerates Stroke Scanner Development
Biotech & Health
Biotech & Health

EMVision Medical Devices (ASX: EMV) Unlocks a 1,700-Hospital Opportunity as Fresh Funding Accelerates Stroke Scanner Development

EMVision Medical Devices ASX: EMV is building momentum towards a potentially significant commercial breakthrough, with a fresh $306,750 government grant payment supporting the expansion of i...

Danny AadDanny Aad•
Loading more stories...